Free Trial

EUROFINS SCIENT (OTCMKTS:ERFSF) Stock Price Up 8% - What's Next?

Eurofins Scient logo with Medical background

Key Points

  • Shares of Eurofins Scient rose 8% recently, trading at $83.02, following a previous close of $76.88.
  • Despite the stock's increase, analysts from HSBC downgraded Eurofins Scient from a "strong-buy" to a "hold" rating, with a consensus rating of "Hold" among six research analysts.
  • The company has a quick ratio of 1.09 and a debt-to-equity ratio of 0.58, indicating a stable financial position.
  • MarketBeat previews top five stocks to own in September.

EUROFINS SCIENT (OTCMKTS:ERFSF - Get Free Report)'s share price was up 8% during trading on Friday . The company traded as high as $83.02 and last traded at $83.02. Approximately 1,081 shares changed hands during trading, a decline of 31% from the average daily volume of 1,566 shares. The stock had previously closed at $76.88.

Analyst Upgrades and Downgrades

A number of analysts recently commented on ERFSF shares. Citigroup reiterated a "neutral" rating on shares of EUROFINS SCIENT in a research report on Friday. HSBC cut EUROFINS SCIENT to a "hold" rating in a research report on Friday, April 25th. Finally, Hsbc Global Res lowered EUROFINS SCIENT from a "strong-buy" rating to a "hold" rating in a research note on Friday, April 25th. Five investment analysts have rated the stock with a hold rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Hold".

Check Out Our Latest Research Report on ERFSF

EUROFINS SCIENT Trading Up 1.5%

The company has a quick ratio of 1.19, a current ratio of 1.26 and a debt-to-equity ratio of 0.77. The firm has a 50 day moving average price of $69.97 and a two-hundred day moving average price of $60.34.

EUROFINS SCIENT Company Profile

(Get Free Report)

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products.

See Also

Should You Invest $1,000 in Eurofins Scient Right Now?

Before you consider Eurofins Scient, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eurofins Scient wasn't on the list.

While Eurofins Scient currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in August 2025
The $2.5B Merger No One Is Talking About
ALERT: Big Tech Earnings – Watch Before Wednesday

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines